Tesamorelin · FDA-approved GHRH analog
The most-studied GH secretagogue.
Tesamorelin is the only GHRH analog with an FDA approval (HIV-associated lipodystrophy). It's the most-studied peptide in this category and the closest to mainstream medicine — which is why physicians often start here for visceral fat and longevity-context protocols.
For the longevity-curious operator who wants the most-studied option in the category.
Licensed physicians
8-state coverage
503B compounding pharmacy
FDA-registered, cGMP-compliant
Cold-chain validated
2–8°C door-to-door
Refundable consult
If the physician declines
First month bundle
$349
Consult + first month’s prescription. Refills $279/mo · about $11.60/day
- Async consult with a licensed physician
- Tesamorelin prescribed at physician-determined dose
- Cold-chain shipped, pen-ready vials
- Conduit pen + 30 pen needles
- IGF-1 lab tracking integrated
- Conduit+ membership for the duration
Refundable consult if the physician declines.
Why people pick this
“I'd already done Function Health. Tracked everything. Tesamorelin was the lever that moved visceral fat and trunk composition when nothing else had.”
Conduit Care user · Longevity protocol
The mechanism, in plain English.
Tesamorelin is a stabilized GHRH analog. Unlike CJC-1295 or sermorelin, it has FDA approval for reducing visceral adipose tissue in HIV-associated lipodystrophy — meaning real Phase 3 data on safety and efficacy exist. Off-label longevity use is mechanistically logical: physiologic GHRH signaling that resets pituitary GH-axis output without exogenous HGH.
- NoteTesamorelin reduced VAT by ~15% over 26 weeks in Phase 3 (Falutz et al., NEJM 2007)
- NoteMechanism: physiologic GHRH signaling, preserves pituitary feedback loop
- NoteHalf-life ~26 minutes; daily SC pre-sleep dosing protocol
- NoteIGF-1 monitoring during cycle; physician adjusts based on labs
What changes, and when.
01 · Week 1–2
Cold-chain shipment arrives. First pre-sleep dose logged.
02 · Week 4
IGF-1 baseline labs. Many users notice improved sleep depth and recovery here.
03 · Week 12
Mid-cycle IGF-1 redraw. Visceral-fat reduction often begins to be measurable.
04 · Week 26
Common cycle endpoint, mirrors the Phase 3 protocol. Off-cycle or maintenance dose.
Three ways to run longevity.
Do nothing
Status quo.
- · No risk, no result
- · Hope it resolves on its own
- · No data captured
- · $0 / month
Self-source
Research-supply gamble.
- · Unverified source + COA
- · No physician oversight
- · Reconstitute yourself
- · Maybe $100–200 / month
Conduit Care
Pharma-grade.
- · 503B pharmacy + COA
- · Physician-supervised
- · Cold-chain shipped, pen-ready
- · $279/mo refill
The physician
Licensed in your state.
Your case is reviewed asynchronously by a physician licensed in your state of residence. They evaluate your medical history, current medications, and contraindications against the requested protocol. They approve, decline, or request more information. They are accountable for the prescription.
24-hour median response
The pharmacy
503B compounding.
An FDA-registered 503B outsourcing facility fills your prescription. cGMP-compliant production. Lot-tracked vials. USP <797> sterile compounding standards. Validated 2–8°C cold-chain transit from the fill line to your door.
FDA-registered, cGMP-compliant
Before you start.
- How is this different from buying research peptides online?
- A licensed physician reviews your medical history and writes a prescription before anything ships. A 503B compounding pharmacy fulfills the prescription — meaning FDA-registered facility, cGMP-compliant production, validated cold-chain transit. Research-supply sites operate without prescription oversight or pharmacy-grade fulfillment. The product, the process, and the accountability are categorically different.
- How long does the review take?
- Most cases are reviewed within 24 hours. The physician may approve, request more information, or decline based on contraindications. If declined, the consult fee is refunded in full.
- Is this telehealth or in-person?
- Asynchronous telehealth only. You complete an intake form, upload an ID, the physician reviews on their own schedule. No video visit required. You can complete the entire intake in under five minutes and the physician responds in under 24 hours.
- What if I already use insulin syringes and vials?
- You can still use Conduit. The Conduit pen accepts the cold-chain reconstituted vials we ship — no draws, no math. If you prefer to keep using syringes, you can buy the pen separately on /shop. The Conduit app tracks doses either way.
- What states do you ship to?
- Conduit Care is currently live in Texas, Tennessee, Oklahoma, Louisiana, Arizona, Georgia, Florida, and New York. Coverage depends on physician licensure and pharmacy reach. We expand quarterly. If your state isn’t live yet, the waitlist is the fastest way to know when it goes live.
Not a guarantee.
Not for everyone.
- · The reviewing physician determines dose, duration, and eligibility based on your intake. They may decline.
- · Longevity protocols are not FDA-approved indications for these peptides. Conduit Care operates within compounded- product framework with licensed physician oversight.
- · Outcomes vary. Conduit doesn’t make therapeutic claims; the platform supports adherence and tracking.
- · Consult fee is refundable if the physician declines. Prescription cost is not refundable once filled.
Working on something else?
Ready
Start your longevity protocol.
A licensed physician reviews in under 24 hours. Refundable if declined.
Conduit products are sterile fluid transfer devices intended for research applications. Conduit Care is a separate asynchronous telehealth service. Not intended for diagnosis, treatment, or prevention of any disease. The Longevity protocol is not an FDA-approved indication for these peptides; it is a compounded-product framework under licensed physician oversight.